Submissions

Author Guidelines

The Editorial Board of „ Cardiology in Practice” takes under consideration for publication original articles with the understanding that neither the manuscript nor any part of its essential substance, tables or figures have been published previously in print form or electronically and are not under consideration by any other publication or electronic medium. This restriction does not apply to abstracts or press reports published in connection with scientific meetings. Copies of any closely related manuscripts should be submitted to the Editor along with the manuscript that is to be considered.

Each submission packet should include the statement signed by the first author that the work has not been published previously or submitted elsewhere for review and a copyright transfer.

Size

Original Investigation (3000–6000 words including tables and figures)

Original investigations are considered full-length applied or basic research reports. They cover topics relevant to clinical and basic studies relevant to man in the following areas cardiology, heart diseases and pharmacology. The work presented in the manuscript must be original; studies related to previous observations will be considered.

Rapid Communication (1000–3000 words including tables, figures)

Rapid Communication presenting succinctly the results of original scientific research. In the cover letter the author should justify the request for Rapid Communication. The review process is 10 days, authors are allowed one revision if accepted, and the final version of the paper appears in the next available issue of the journal.

Research Letter (up to 1000 words, including up to 10 references and 1 figure or table)

A Research Letter contains new data or a clinical observation, in a format that allows for rapid publication.

Review Article (up to 5000 words including tables, figures)

In-depth, comprehensive state of the art reviews on a cardiology topics are welcomed. The editor may invite the authors to prepare the review article.

Case Report (up to 2500 words including tables and figures)

Case Reports include case studies of 4 or fewer patients that describe a novel situation or add important insights into mechanisms, diagnosis or treatment of a disease.

Letter to the Editor (1000 words including tables, figures)

Opinion pieces concerning papers are particularly welcomed and all submissions are subject to editing. Letters commenting on past-published papers are sent to the corresponding author for a response. Letters are selected for their relevance and originality; not all letters submitted can be published.

Meeting Proceedings (up to 2500 words including tables, figures)

Reports of meeting proceedings are synopses of scientific meetings of interest to audience of the journal.

Hypothesis (up to 3000 words including tables and figures)

Novel insights into a significant questions or clinical issues are welcome, and will be peer reviewed. As the definition of „hypothesis” suggests, articles of this type should be, although they lack direct experimental evidence, closely tied to empirical data and lead to testable predictions.

Special Article (up to 5000 words including tables and figures)

Special Article is associated with a particular special event.

 

SUBMISSIONS

Submission to this journal proceeds totally online. Paper can be submitted as a PDF file or a Word document. It should contain high enough quality figures. Please note that individual figure files larger than 10 MB must be uploaded separately.

Essential title page information

Title. Concise and informative. Titles are often used in information-retrieval systems. Avoid abbreviations and formulae where possible.

Author names and affiliations. Please clearly indicate the given name(s) and family name(s) of each author and check that all names are accurately spelled. Indicate ORCiD number. Present the authors' affiliation addresses (where the actual work was done) below the names. Provide the full postal address of each affiliation, including the country name and, if available, the e-mail address of each author.

Corresponding author. Clearly indicate who will handle correspondence at all stages of refereeing and publication, also post-publication. This responsibility includes answering any future queries about Methodology and Materials. Ensure that the e-mail address is given and that contact details are kept up to date by the corresponding author.

Present/permanent address. If an author has moved since the work described in the article was done, or was visiting at the time, a 'Present address' (or 'Permanent address') may be indicated as a footnote to that author's name. The address at which the author actually did the work must be retained as the main, affiliation address. Superscript Arabic numerals are used for such footnotes.

References

Indicate references by number(s) in square brackets in line with the text. The actual authors can be referred to, but the reference number(s) must always be given.

Number the references in the list in the order in which they appear in the text. References should be given according to the Vancouver style, according to the following formula:

1. Kowalski J, Nowak B, Nowakowski RBA. 1^st Baltic Cardio-Oncology Meeting. OncoReview. 2010; 163: 51-9. https://doi.org/10.1016/j.Sc.2010.00372.

Reference to a journal publication with an article number:

2. Kowalski J, Nowak B, Nowakowski RBA. 1^st Baltic Cardio-Oncology Meeting. OncoReview. 2018; 19: e00205. https://doi.org/10.1016/j.heliyon.2018.e00205

Reference to a book:

3. Johnes Jr W, White EB. Cardiovascular complications in cancer. 4^th ed. Medical Education; Warszawa 2010.

Reference to a chapter in an edited book:

4. Mettam GR, Adams LB. Cardiotoxicity in breast cancer. In: Johnes Jr W, White EB. Cardiovascular complications in cancer. Medical Education; Warszawa 2010, p. 281-304.

Reference to a website:

5. Cancer Research UK. Cancer statistics reports for the UK, http://www.cancerresearchuk.org/aboutcancer/statistics/cancerstatsreport/; 2003 (accessed 13 March 2003).

Reference to a dataset:

6. Oguro M, Imahiro S, Saito S, Nakashizuka T. Mortality data for Japanese oak wilt disease and surrounding forest compositions, Mendeley Data, v1; 2015. https://doi.org/10.17632/xwj98nb39r.1.

Use of DOI is highly encouraged.

Note shortened form for last page number. e.g., 51-9. For more than 6 authors the first 6 should be listed followed by 'et al.'

Journal names should be abbreviated according to the List of Title Word Abbreviations.

Formatting requirements

There are no strict formatting requirements but all manuscripts must contain the essential elements needed to convey your manuscript, for example

• Abstract

• Keywords

• Introduction

• Materials and Methods

• Results

• Conclusions.

If your article includes any Videos and/or other Supplementary material, this should be included in your initial submission for peer review purposes.

Abstract

Abstracts should be no more than 250 words. The structured abstract for an original investigation should be organized as follows: objective, research methods & procedures, data/methods provided and referenced, results, conclusion.

Keywords

5–7 key words or phrases should be provided which should be selected from the body of the text and not duplicate title words.

Abbreviations

Abbreviations must be defined at their first mention. Ensure consistency of abbreviations throughout the article.

Acknowledgments

Collate acknowledgements in a separate section at the end of the article before the references List here those individuals who provided help during the research (e.g., providing language help).

Formatting of funding sources

List funding sources in this way:

Funding: This work was supported by the XXX [grant number].

If no funding has been provided for the research, please include the following sentence:

This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

Units

Follow internationally accepted rules and conventions: use the international system of units (SI). If other units are mentioned, please give their equivalent in SI.

Tables

Please submit tables as editable text and not as images. Tables can be placed either next to the relevant text in the article, or on separate page(s) at the end. Number tables consecutively in accordance with their appearance in the text and place any table notes above the table body. The data presented in table do not duplicate results described elsewhere in the article.

Manuscript submissions should conform to the guidelines set forth in the “Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals (ICMJE Recommendations),” available online at: www.icmje.org/recommendations.
All material submitted to “Alergoprofil. Journal of allergens, pollens and spores”, for any section of the journal, is considered that authors (including all coauthors) agree to journal's publication policies
In the event of non-compliance with conditions of publication, including authors’ contribution, Editorial Board rights include: sending a notice of failure to comply to authors' employers and funding agencies; and/or informing readers via a published correction/retraction.

Research/publication misconduct is a serious breach of ethics. Such misconduct includes:
• duplicate publication by same author(s)
• publication in another source by the same author(s) without acknowledgement
• plagiarism or self-plagiarism (publication of material without acknowledging original author source)
• fabrication of data, not substantiable via review of research records
Should such publications occur, editorial action would be taken. In certain cases, secondary publication is justifiable and even beneficial; however, such circumstances should be prospectively discussed with and agreed upon by the Editor-In-Chief.
Journal will not accept a submission of work previously reported in large part in a published article (duplicate) or that is contained in another paper submitted or accepted for publication elsewhere.

Human and animal rights
If the work involves the use of human subjects, the author(authors) should ensure that the work described has been carried out in accordance with The Code of Ethics of the World Medical Association (Declaration of Helsinki) for experiments involving humans. Authors should include a statement in the manuscript that informed consent was obtained for experimentation with human subjects. The privacy rights of human subjects must always be observed.
All animal experiments should comply with the ARRIVE guidelines and should be carried out in accordance with EU Directive 2010/63/EU for animal experiments and the authors should clearly indicate in the manuscript that such guidelines have been followed.

Declaration of interest
All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence (bias) their work. Examples of potential conflicts of interest include employment, consultancies, stock ownership, honoraria, paid expert testimony, patent applications/ registrations, and grants or other funding. If there are no interests to declare then please state this: “Conflict of interest: none”. This summary statement will be ultimately published if the article is accepted..

Submission declaration
Submission of an article implies that the work described has not been published previously that it is not under consideration for publication elsewhere, that its publication is approved by all authors and tacitly or explicitly by the responsible authorities where the work was carried out, and that, if accepted, it will not be published elsewhere in the same form, in English or in any other language, including electronically without the written consent of the copyright-holder.

Contributors
Each author is required to declare his or her individual contribution to the article: all authors must have materially participated in the research and/or article preparation, so roles for all authors should be described.

Changes to authorship
After submission any changes in the authorship list could be made only before the manuscript has been accepted and only if approved by the journal Editor. To request such a change, the Editor must receive the following from the corresponding author: (a) the reason for the change in author list and (b) written confirmation (e-mail, letter) from all authors that they agree with proposed change. In the case of addition or removal of authors, this includes confirmation from the author being added or removed.
Only in exceptional circumstances will the Editor consider the addition, deletion or rearrangement of authors after the manuscript has been accepted. While the Editor considers the request, publication of the manuscript will be suspended. If the manuscript has already been published in an online issue, any requests approved by the Editor will result in a corrigendum.

Clinical trials
In line with the position of the International Committee of Medical Journal Editors, the journal will not consider results posted in the same clinical trials registry in which primary registration resides to be prior publication if the results posted are presented in the form of a brief structured (less than 500 words) abstract or table. However, divulging results in other circumstances (e.g., investors' meetings) is discouraged and may jeopardise consideration of the manuscript. Authors should fully disclose all posting in registries of results of the same or closely related work.
Registration in a public trials registry is a condition for publication of clinical trials in this journal in accordance with International Committee of Medical Journal Editors recommendations. Trials must register at or before the onset of patient enrolment. The clinical trial registration number should be included at the end of the abstract of the article. A clinical trial is defined as any research study that prospectively assigns human participants or groups of humans to one or more health-related interventions to evaluate the effects of health outcomes. Health-related interventions include any intervention used to modify a biomedical or health-related outcome (for example drugs, surgical procedures, devices, behavioural treatments, dietary interventions, and process-of-care changes). Health outcomes include any biomedical or health-related measures obtained in patients or participants, including pharmacokinetic measures and adverse events. Purely observational studies (those in which the assignment of the medical intervention is not at the discretion of the investigator) will not require registration.
Randomized controlled trials should be presented according to the CONSORT guidelines. At manuscript submission, authors must provide the CONSORT checklist accompanied by a flow diagram that illustrates the progress of patients through the trial, including recruitment, enrollment, randomization, withdrawal and completion, and a detailed description of the randomization procedure.

Copyrights
Submitting a paper is tantamount to an automatic and free-of-charge transfer of copyright (to publish and distribute the submitted material in all forms and fields of exploitation known now and developed in the future) to the Publisher, on condition that those materials are accepted for publication.

The names and e-mail addresses submitted with the article will be used exclusively for editorial purposes of this journal and correspondence, and will not be made available for any other purpose or to any other party.

Ensure that the following information and files have been included and one author has been designated as the corresponding author with contact details: E-mail address Full postal address

Manuscript: Word doc or similar required. PDF is not suitable for review and production. Include keywords. Has been spell-checked and grammar checked.

Tables: Include titles, description, footnotes. Create tables in the editable document, so that changes can be made.

Figures: High quality and good resolution. Provide separate image files as well as in the manuscript. Include relevant captions.

References
Make sure the references mentioned in the Reference List are cited in the text, and vice versa. Make sure the reference style is Vancouver style and is consistent throughout.

Further considerations
Make sure that all permission has been obtained for use of copyrighted material from other sources (including the Internet). Journal policies have been reviewed.